Filana Therapeutics receives Nasdaq notice for sub — $1 minimum bid price noncompliance
Nasdaq flagged Filana Therapeutics for noncompliance with the $1 minimum bid-price rule after 30 straight business days below $1. Shares keep trading on the Nasdaq Capital Market under FLNA while the company gets 180 days, until March 16, 2027, to regain compliance. Compliance requires a closing bid price of at least $